140 related articles for article (PubMed ID: 22069281)
1. Zinc transporter 8 autoantibodies in fulminant, acute-onset, and slow-onset patients with type 1 diabetes.
Kawasaki E; Nakamura K; Kuriya G; Satoh T; Kobayashi M; Kuwahara H; Abiru N; Yamasaki H; Matsuura N; Miura J; Uchigata Y; Eguchi K
Diabetes Metab Res Rev; 2011 Nov; 27(8):895-8. PubMed ID: 22069281
[TBL] [Abstract][Full Text] [Related]
2. Differences in the humoral autoreactivity to zinc transporter 8 between childhood- and adult-onset type 1 diabetes in Japanese patients.
Kawasaki E; Nakamura K; Kuriya G; Satoh T; Kobayashi M; Kuwahara H; Abiru N; Yamasaki H; Matsuura N; Miura J; Uchigata Y; Eguchi K
Clin Immunol; 2011 Feb; 138(2):146-53. PubMed ID: 21067978
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
[TBL] [Abstract][Full Text] [Related]
4. Detection and characterization of ZnT8 autoantibodies could help to screen latent autoimmune diabetes in adult-onset patients with type 2 phenotype.
Trabucchi A; Faccinetti NI; Guerra LL; Puchulu FM; Frechtel GD; Poskus E; Valdez SN
Autoimmunity; 2012 Mar; 45(2):137-42. PubMed ID: 21875382
[TBL] [Abstract][Full Text] [Related]
5. Characterization of zinc transporter 8 (ZnT8) antibodies in autoimmune diabetic patients from Argentinian population using monomeric, homodimeric, and heterodimeric ZnT8 antigen variants.
Faccinetti NI; Guerra LL; Penas Steinhardt A; Iacono RF; Frechtel GD; Trifone L; Poskus E; Trabucchi A; Valdez SN
Eur J Endocrinol; 2016 Feb; 174(2):157-65. PubMed ID: 26567119
[TBL] [Abstract][Full Text] [Related]
6. Novel enzyme-linked immunosorbent assay for bivalent ZnT8 autoantibodies.
Kawasaki E; Tanaka M; Miwa M; Abiru N; Kawakami A
Acta Diabetol; 2014; 51(3):429-34. PubMed ID: 24292540
[TBL] [Abstract][Full Text] [Related]
7. Association between anti-ZnT8 autoantibody specificities and SLC30A8 Arg325Trp variant in Japanese patients with type 1 diabetes.
Kawasaki E; Uga M; Nakamura K; Kuriya G; Satoh T; Fujishima K; Ozaki M; Abiru N; Yamasaki H; Wenzlau JM; Davidson HW; Hutton JC; Eguchi K
Diabetologia; 2008 Dec; 51(12):2299-302. PubMed ID: 18850084
[TBL] [Abstract][Full Text] [Related]
8. A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetes.
Vaziri-Sani F; Delli AJ; Elding-Larsson H; Lindblad B; Carlsson A; Forsander G; Ivarsson SA; Ludvigsson J; Marcus C; Lernmark Å
J Immunol Methods; 2011 Aug; 371(1-2):25-37. PubMed ID: 21708156
[TBL] [Abstract][Full Text] [Related]
9. Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects.
Wenzlau JM; Walter M; Gardner TJ; Frisch LM; Yu L; Eisenbarth GS; Ziegler AG; Davidson HW; Hutton JC
J Clin Endocrinol Metab; 2010 Oct; 95(10):4712-9. PubMed ID: 20610599
[TBL] [Abstract][Full Text] [Related]
10. A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes.
Wenzlau JM; Liu Y; Yu L; Moua O; Fowler KT; Rangasamy S; Walters J; Eisenbarth GS; Davidson HW; Hutton JC
Diabetes; 2008 Oct; 57(10):2693-7. PubMed ID: 18591387
[TBL] [Abstract][Full Text] [Related]
11. Zinc transporter 8 (ZnT8) autoantibody epitope specificity and affinity examined with recombinant ZnT8 variant proteins in specific ZnT8R and ZnT8W autoantibody-positive type 1 diabetes patients.
Skärstrand H; Krupinska E; Haataja TJ; Vaziri-Sani F; Lagerstedt JO; Lernmark Å
Clin Exp Immunol; 2015 Feb; 179(2):220-9. PubMed ID: 25178386
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes.
Kawasaki E; Nakamura K; Kuriya G; Satoh T; Kuwahara H; Kobayashi M; Abiru N; Yamasaki H; Eguchi K
J Clin Endocrinol Metab; 2010 Feb; 95(2):707-13. PubMed ID: 20061424
[TBL] [Abstract][Full Text] [Related]
13. Zinc transporter 8 autoantibodies complement glutamic acid decarboxylase and insulinoma-associated antigen-2 autoantibodies in the identification and characterization of Japanese type 1 diabetes.
Kawasaki E; Oikawa Y; Okada A; Kanatsuna N; Kawamura T; Kikuchi T; Terasaki J; Miura J; Ito Y; Hanafusa T
J Diabetes Investig; 2020 Sep; 11(5):1181-1187. PubMed ID: 32175683
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to zinc transporter 8 and SLC30A8 genotype stratify type 1 diabetes risk.
Achenbach P; Lampasona V; Landherr U; Koczwara K; Krause S; Grallert H; Winkler C; Pflüger M; Illig T; Bonifacio E; Ziegler AG
Diabetologia; 2009 Sep; 52(9):1881-8. PubMed ID: 19590848
[TBL] [Abstract][Full Text] [Related]
15. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.
Andersson C; Vaziri-Sani F; Delli A; Lindblad B; Carlsson A; Forsander G; Ludvigsson J; Marcus C; Samuelsson U; Ivarsson S; Lernmark A; Larsson HE;
Pediatr Diabetes; 2013 Mar; 14(2):97-105. PubMed ID: 22957668
[TBL] [Abstract][Full Text] [Related]
16. Changes in Zinc Transporter 8 Autoantibodies Following Type 1 Diabetes Onset: The Type 1 Diabetes Genetics Consortium Autoantibody Workshop.
Wenzlau JM; Frisch LM; Hutton JC; Fain PR; Davidson HW
Diabetes Care; 2015 Oct; 38 Suppl 2(Suppl 2):S14-20. PubMed ID: 26405067
[TBL] [Abstract][Full Text] [Related]
17. Zinc transporter 8 autoantibodies in patients with type 1 diabetes from a multiethnic population and their first degree relatives.
Araujo DB; Skärstrand H; Barone B; Dantas JR; Kupfer R; Zajdenverg L; Milech A; Vaziri-Sani F; Oliveira JE; Rodacki M
Arq Bras Endocrinol Metabol; 2014 Oct; 58(7):737-43. PubMed ID: 25372583
[TBL] [Abstract][Full Text] [Related]
18. Zinc transporter type 8 autoantibodies (ZnT8A): prevalence and phenotypic associations in latent autoimmune diabetes patients and patients with adult onset type 1 diabetes.
Andersen MK; Härkönen T; Forsblom C; Groop PH; Knip M; Tuomi T
Autoimmunity; 2013 Jun; 46(4):251-8. PubMed ID: 23194113
[TBL] [Abstract][Full Text] [Related]
19. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.
Gorus FK; Balti EV; Vermeulen I; Demeester S; Van Dalem A; Costa O; Dorchy H; Tenoutasse S; Mouraux T; De Block C; Gillard P; Decochez K; Wenzlau JM; Hutton JC; Pipeleers DG; Weets I;
Clin Exp Immunol; 2013 Jan; 171(1):82-90. PubMed ID: 23199327
[TBL] [Abstract][Full Text] [Related]
20. Zinc transporter-8 autoantibodies improve prediction of type 1 diabetes in relatives positive for the standard biochemical autoantibodies.
Yu L; Boulware DC; Beam CA; Hutton JC; Wenzlau JM; Greenbaum CJ; Bingley PJ; Krischer JP; Sosenko JM; Skyler JS; Eisenbarth GS; Mahon JL;
Diabetes Care; 2012 Jun; 35(6):1213-8. PubMed ID: 22446173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
